TOKYO -- New treatments for ALS are progressing little by little, with companies like U.S.-based Biogen and Japan's Otsuka Pharmaceutical working to give hope to patients of the incurable disease.
Pharmaceuticals
US, Japan drugmakers target ALS-causing genes with new therapies
Biogen, Otsuka and others find novel ways to fight debilitating disease
Biogen released a drug that acts on a protein that can cause ALS in Japan in March. (Biogen)
Read Next
Latest on Pharmaceuticals
